CD63 and nasopharyngeal carcinoma: Importantly, it was shown that when Cyclophilin A levels in CD63+/TSG101+/HSP70+ EVs were combined with EBV viral capsid antigen (VCA-IgA) levels, they acted synergistically to provide a combinatorial biomarker with improved accuracy of NPC diagnosis.